Evidence map›Paper›PMID 25431235›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2015

Nuclear expression and gain-of-function β-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker.

Jerzy Lasota, Anna Felisiak-Golabek, F Zahra Aly, Zeng-Feng Wang, Lester D R Thompson, Markku Miettinen

Open access · bronzeAbstract read
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 85 citations in OpenAlex.

  1. Diagnostic Insights and Surgical Outcomes of Glomangiopericytoma: A Tertiary Center Case Series.Journal of rhinology : official journal of the Korean Rhinologic Society · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Utility of LEF1 to differentiate desmoid fibromatosis from its histologic mimics.Virchows Archiv : an international journal of pathology · 2024
    Article
  7. Article
  8. Review
  9. Glomangiopericytoma withBMJ case reports · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Sinonasal Glomangiopericytoma with Prolonged Postsurgical Follow-Up.Journal of neurological surgery reports · 2022
    Article
  14. Review
  15. Cold Spring Harbor molecular case studies · 2022
    Article
  16. Article
  17. Loss of CTNNB1 exon 3 in sclerosing angiomatoid nodular transformation of the spleen.Virchows Archiv : an international journal of pathology · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jerzy LasotaLaboratory of Pathology, National Cancer Institute (NCI), Bethesda, MD, USA.
Anna Felisiak-GolabekLaboratory of Pathology, National Cancer Institute (NCI), Bethesda, MD, USA.
F Zahra AlyDepartment of Pathology, University of Arizona, Tucson, AZ, USA.
Zeng-Feng WangLaboratory of Pathology, National Cancer Institute (NCI), Bethesda, MD, USA.
Lester D R ThompsonDepartment of Pathology, Southern California Permanente Medical Group, Woodland Hills, CA, USA.
Markku MiettinenLaboratory of Pathology, National Cancer Institute (NCI), Bethesda, MD, USA.
National Cancer Institute · USUniversity of Arizona · USWoodland Hills Medical Center · US

Funding

Genreal Surgical PathologyZIDBC011291 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MIETTINEN, MARKKU · 2010 to 2025
$30.3M
Immunohistochemical and genomic analysis of tumorsZIABC011427 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MIETTINEN, MARKKU · 2012 to 2025
$24.0M
Intramural NIH HHS ZIA BC011427Intramural NIH HHS ZID BC011291
6 · The paper itself

Abstract

Glomangiopericytoma (sinonasal-type hemangiopericytoma) is a rare mesenchymal neoplasm with myoid phenotype (smooth muscle actin-positive), which distinguishes this tumor from soft tissue hemangiopericytoma/solitary fibrous tumor. Molecular genetic changes underlying the pathogenesis of glomangiopericytoma are not known. In this study, 13 well-characterized glomangiopericytomas were immunohistochemically evaluated for β-catenin expression. All analyzed tumors showed strong expression and nuclear accumulation of β-catenin. Following this observation, β-catenin glycogen serine kinase-3 beta phosphorylation region, encoded by exon 3, was PCR amplified in all cases and evaluated for mutations using Sanger sequencing. Heterozygous mutations were identified in 12 of 13 tumors. All mutations consisted of single-nucleotide substitutions: three in codon 32 (c.94G>C (n=2) and c.95A>T), four in codon 33 (two each c.98C>G and c.98C>T), two in codon 37 (c.109T>G), one in codon 41 (c.121A>G), and two in codon 45 (c.133T>C). At the protein level, these substitutions would lead to p.D32H, p.D32V, p.S33C, p.S33F, p.S37A, p.T41A, and p.S45L mutations, respectively. Previously, similar mutations have been reported in different types of cancers and shown to trigger activation of β-catenin signaling. All analyzed glomangiopericytomas showed prominent nuclear expression of cyclin D1, as previously shown for tumors with nuclear expression of β-catenin as a sign of oncogenic activation. These results demonstrate that mutational activation of β-catenin and associated cyclin D1 overexpression may be central events in the pathogenesis of glomangiopericytoma. In additon, nuclear accumulation of β-catenin is a diagnostic marker for glomangiopericytoma.

Indexed as

MutationAgedbeta CateninBiomarkers, TumorCell NucleusCyclin D1FemaleHemangiopericytomaHumansImmunohistochemistryMaleNose NeoplasmsParanasal SinusesReverse Transcriptase Polymerase Chain Reactionbeta CateninBiomarkers, TumorCCND1 protein, humanCTNNB1 protein, humanCyclin D1

Identifiers

PMID25431235
PMCPMC7712456
OpenAlexW2039284599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.